India  

BBIL to provide 16.50 lakh doses of COVAXIN for free to GoI: Health Ministry

Video Credit: ANI - Duration: 01:23s - Published
BBIL to provide 16.50 lakh doses of COVAXIN for free to GoI: Health Ministry

BBIL to provide 16.50 lakh doses of COVAXIN for free to GoI: Health Ministry

Bharat Biotech to provide 16.50 lakh doses of COVAXIN for free of cost to the Central government as a special gesture, informed Union Health Ministry during a press briefing on January 12.

"The Government of India agreed to procure 110 lakh Covishield vaccine doses from Serum Institute of India (SII) at Rs 200/dose.

55 lakh doses of COVAXIN to be procured from Bharat Biotech (BBIL), of which 38.5 lakh doses priced at Rs 295/dose," said Union Health Secretary Rajesh Bhushan.

He added, "BBIL will provide 16.50 lakh doses of COVAXIN free of cost to the Central govt as a special gesture."


You Might Like


💡 newsR Knowledge: Other News Mentions

BBV152 BBV152 Vaccine against COVID-19

Covid vaccine: How many Indians got jab on Day 1? Govt reveals [Video]

Covid vaccine: How many Indians got jab on Day 1? Govt reveals

At least 1,65,714 healthcare beneficiaries received COVID-19 jab on Saturday across India, marking it as a historic and biggest COVID-19 vaccination drive launched by Prime Minister Narendra Modi. About 16,755 total vaccinators involved across India during the COVID vaccination drive. There was no post adverse event reported after the vaccination was administered to the people. "Total vaccinators involved across India were 16,755. Total beneficiaries vaccinated across India--1,65,714. COVID19 vaccination drive was successful on Day 1. No case of post-vaccination hospitalisation reported so far," said Manohar Agnani, Additional Secretary of Union Health Ministry. "The Serum Institute of India (SII) produced COVISHIELD was supplied to all States and Union Territories (UT). Bharat Biotech's COVAXIN was supplied to 12 States. Total 3,351 sessions were held across the country with both the vaccines, said Health Ministry on COVID19 vaccine roll-out," he added. Watch the full video for more details.

Credit: HT Digital Content    Duration: 06:46Published
First feeling, side-effects, doubts: Vaccinated doctors share experience [Video]

First feeling, side-effects, doubts: Vaccinated doctors share experience

On Day 1 of India's Covid-19 vaccination, two doctors who took the shots shared their experience. Dr Atul Peters and Anil Dhar of Max hospital were given Bharat Biotech's Covaxin and SII-made Covishield jabs respectively. Both didn't experience any side-effects and said that doubts regarding the inoculants are unfounded. Dr Suranjit Chatterjee of Apollo hospital, who is set to receive a shot soon, also weighed in on the controversy regarding Covaxin and its third phase trials. Watch the full video for more.

Credit: HT Digital Content    Duration: 08:15Published

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Covid: Dr VK Paul, AIIMS director urge people to trust researchers on vaccine [Video]

Covid: Dr VK Paul, AIIMS director urge people to trust researchers on vaccine

Urging the people to have faith in India's researchers, scientists, regulatory authorities, All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Singh Guleria on Saturday reassured the nation that Bharat Biotech's COVAXIN vaccine is safe. Dr Guleria along with NITI Aayog member VK Paul were administered the COVID-19 vaccine shot at AIIMS Delhi on the inaugural day of the nationwide roll-out of vaccination on Saturday. Talking about the experience, he said, "I am humbled to get vaccinated in the first slot and feel so proud. I hope more and more people come forward when it comes to getting vaccinated so that we can reduce mortality and prevent the spread of COVID-19 infection." Dr VK Paul said that the vaccine is safe and people should trust the scientific process. Watch the full video for more details.

Credit: HT Digital Content    Duration: 03:41Published

Government of India Government of India Legislative, executive and judiciary powers of India

Envoy calls Indian embassy in Estonia a 'New Year gift' for citizens [Video]

Envoy calls Indian embassy in Estonia a 'New Year gift' for citizens

Estonia's envoy to India Katrin Kivi on GoI's decision to open a mission in Estonia expressed happiness. She called it a 'New Year gift' for Estonia. "It is a pleasure to address India's decision to open a resident mission in Estonia. This was really a kind of Christmas or New Year gift for the entire Estonia nation. We are very happy about it. This is proof of our bilateral relations. It's important for our trade relations but also politically as India and Estonia are good partners, this year we've also started working together in UNSC," said Estonia's envoy to India.

Credit: ANI    Duration: 01:27Published
Serum Institute of India dispatches 'Covishield' vaccine across India [Video]

Serum Institute of India dispatches 'Covishield' vaccine across India

The first batch of COVID-19 vaccine 'Covishield' was dispatched by Serum Institute of India (SII) in Pune across India on January 12. SII produces 70-80 million doses of the COVID vaccine every month. India currently has the highest production capability across the globe. SII is selling the vaccine at Rs 200 for the first 100 million doses only to Government of India. The price will mount to Rs 1, 000 in the private market. Serum Institute of India has a partnership with private players for trucks, vans and cold storage for the successful and safe supply of the vaccine. First phase of COVID vaccination drive will start in India from Jan 16.

Credit: ANI    Duration: 01:40Published

Serum Institute of India Serum Institute of India Indian biotechnological company, vaccine manufacturer

Nepal: People cheers after approval of Covishield vaccine manufactured in India [Video]

Nepal: People cheers after approval of Covishield vaccine manufactured in India

After Nepal government approved emergency use of Covishield vaccine, people are hoping the pandemic will falter and human lives would be back on track. Nepal's Department of Drug Administration on Friday issued a release giving information on approving Covishield developed by AstraZeneca and Oxford University, which will be manufactured by Serum Institute of India (SII) in India. Drug regulating authority has also specified Serum Institute of India for importers provided with low cost in purchasing and delivery of vaccine to public. Approving the vaccine for conditional purpose, the department has also asked manufacturers or importers to get approval for registration in order to bring the vaccines. Nepal imposed nationwide and partial lockdown for most of 2020 with rise in imported cases which later took the form of local transmission spreading mostly in urban areas and major cities. The nationwide lockdown which started in March 2020 hampered daily life of people as well as businesses. They now expect to thrive with the approval of vaccine. Though the detailed inoculation plan of Nepal Government is yet to be disclosed, a total of 3 companies applied for approval to take steps forward with Serum Institute for import of vaccines. India has already made conditional emergency approval for Covishield manufactured by the Serum Institute. Being one of the largest producers of vaccines at low cost, India has promised to provide vaccine to its neighbours in near future.

Credit: ANI    Duration: 02:39Published

AZD1222 AZD1222 Vaccine against COVID-19


Related videos from verified sources

'Beginning of the end of Covid-19': Harsh Vardhan on India's vaccination drive [Video]

'Beginning of the end of Covid-19': Harsh Vardhan on India's vaccination drive

Union health minister Dr Harsh Vardhan said that the vaccination drive is 'beginning of the end of covid-19'. He reviewed the preparedness ahead of the Covid-19 vaccination drive in India. "World's..

Credit: HT Digital Content     Duration: 03:02Published
Covid: How much will Covishield, Covaxin, other vaccines cost? Centre reveals [Video]

Covid: How much will Covishield, Covaxin, other vaccines cost? Centre reveals

Union Health Secretary Rajesh Bhushan on Tuesday said the COVID-19 vaccine may cost in the range of Rs 200 to 295 in India and two vaccines -- Covishield and Covaxin -- have received Emergency Use..

Credit: HT Digital Content     Duration: 06:57Published
Around 5.56 lakh COVID vaccine doses dispatched from Pune: TN Principal Health Secy [Video]

Around 5.56 lakh COVID vaccine doses dispatched from Pune: TN Principal Health Secy

On January 12, the Principal Secretary of Health and Family Welfare Department of Tamil Nadu, J Radhakrishnan spoke on COVID-19 vaccine distribution process. He said, "Around 5.56 lakh vaccine doses..

Credit: ANI     Duration: 02:22Published